NASDAQ: PTGX · Health Technology
Which UK funds hold Protagonist Therapeutics, Inc. (PTGX)?
39 of the UK funds Fundology covers list Protagonist Therapeutics, Inc. (PTGX) among their published holdings. The largest weight is 0.60% of iShares NASDAQ US Biotechnology UCITS ETF, as of 29/09/2026.
UK funds that hold Protagonist Therapeutics, Inc.
39 funds, largest weight first. A weight is the share of the fund’s money in this company.
Source: fund issuers’ published holdings, dates differ by fund
About Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. is listed on NASDAQ under the symbol PTGX, in the health technology sector as TradingView classifies it. Its market value was about $9.2bn (in US dollars) on 01/10/2026.
A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.
The list above comes from holdings the fund issuers publish, each dated. Some issuers publish every position; others publish only the largest ten, so a fund can hold Protagonist Therapeutics, Inc. without being listed here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.
Share price
- Latest price
- $142.90
- +1.43%on the day
- 52-week range
- $62.24–$160.81
- Price change, 1 year
- +116.5%
- Price change, this year
- +65.1%
- Market value
- $9.2bn
- Price to earnings (12 months)
- 137.8
Source: TradingView, as of , at least 15 min delayed